Pathstone Holdings, LLC Haemonetics Corp Transaction History
Pathstone Holdings, LLC
- $21.9 Billion
- Q2 2024
A detailed history of Pathstone Holdings, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 3,148 shares of HAE stock, worth $234,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,148
Previous 2,491
26.37%
Holding current value
$234,777
Previous $212,000
22.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.2MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$516 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$444 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$383 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$286 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$286 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.83B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...